Potential Resistance of SARS-CoV-2 Main Protease (Mpro) against Protease Inhibitors: Lessons Learned from HIV-1 Protease
出版年份 2022 全文链接
标题
Potential Resistance of SARS-CoV-2 Main Protease (Mpro) against Protease Inhibitors: Lessons Learned from HIV-1 Protease
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 7, Pages 3507
出版商
MDPI AG
发表日期
2022-03-24
DOI
10.3390/ijms23073507
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern
- (2022) Laura Vangeel et al. ANTIVIRAL RESEARCH
- SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination
- (2022) Pengfei Li et al. CELL RESEARCH
- The Battle between Host and SARS-CoV-2: Innate Immunity and Viral Evasion Strategies
- (2022) Shilei Zhang et al. MOLECULAR THERAPY
- Main protease mutants of SARS-CoV-2 variants remain susceptible to nirmatrelvir
- (2022) Sven Ullrich et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- What coronavirus 3C‐like protease tells us: From structure, substrate selectivity, to inhibitor design
- (2021) Muya Xiong et al. MEDICINAL RESEARCH REVIEWS
- Author Correction: Exploring the structural distribution of genetic variation in SARS-CoV-2 with the COVID-3D online resource
- (2021) Stephanie Portelli et al. NATURE GENETICS
- Repositioning HIV protease inhibitors and nucleos(t)ide RNA polymerase inhibitors for the treatment of SARS-CoV-2 infection and COVID-19
- (2021) Nils von Hentig EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Screening of drug databank against WT and mutant main protease of SARS-CoV-2: Towards finding potential compound for repurposing against COVID-19
- (2021) Tanuj Sharma et al. SAUDI JOURNAL OF BIOLOGICAL SCIENCES
- Identification of mutation resistance coldspots for targeting the SARS‐CoV2 main protease
- (2021) Navaneethakrishnan Krishnamoorthy et al. IUBMB LIFE
- Is PF-00835231 a Pan-SARS-CoV-2 Mpro Inhibitor? A Comparative Study
- (2021) Mohammad Hassan Baig et al. MOLECULES
- Considerations for the Discovery and Development of 3-Chymotrypsin-Like Cysteine Protease Inhibitors Targeting SARS-CoV-2 Infection
- (2021) Koen Vandyck et al. Current Opinion in Virology
- Virtual Alanine Scan of the Main Protease Active Site in Severe Acute Respiratory Syndrome Coronavirus 2
- (2021) Tomoki Nakayoshi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Exploring the Binding Mechanism of PF-07321332 SARS-CoV-2 Protease Inhibitor through Molecular Dynamics and Binding Free Energy Simulations
- (2021) Bilal Ahmad et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease
- (2021) Elizabeth A. MacDonald et al. ACS Infectious Diseases
- Cellular host factors for SARS-CoV-2 infection
- (2021) Jim Baggen et al. Nature Microbiology
- SARS-CoV-2 Quasispecies Provides an Advantage Mutation Pool for the Epidemic Variants
- (2021) Fengming Sun et al. Microbiology Spectrum
- Cellular senescence as a source of SARS‐CoV‐2 quasispecies
- (2021) Ioannis Karakasiliotis et al. FEBS Journal
- A Review of the Current Landscape of SARS-CoV-2 Main Protease Inhibitors: Have We Hit the Bullseye Yet?
- (2021) Guillem Macip et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Characterization of the non-covalent interaction between the PF-07321332 inhibitor and the SARS-CoV-2 main protease
- (2021) Marina Macchiagodena et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management
- (2021) Joseph Heskin et al. LANCET
- Structures and functions of coronavirus replication–transcription complexes and their relevance for SARS-CoV-2 drug design
- (2021) Brandon Malone et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Mechanisms of SARS-CoV-2 entry into cells
- (2021) Cody B. Jackson et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- SCoV2-MD: a database for the dynamics of the SARS-CoV-2 proteome and variant impact predictions
- (2021) Mariona Torrens-Fontanals et al. NUCLEIC ACIDS RESEARCH
- An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19
- (2021) Dafydd R. Owen et al. SCIENCE
- Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19
- (2021) Britton Boras et al. Nature Communications
- Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CLpro substrate degradome
- (2021) Isabel Pablos et al. Cell Reports
- A structural view of the SARS-CoV-2 virus and its assembly
- (2021) Nathan J Hardenbrook et al. Current Opinion in Virology
- Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332
- (2021) Yao Zhao et al. Protein & Cell
- Michaelis-like complex of SARS-CoV-2 main protease visualized by room-temperature X-ray crystallography
- (2021) Daniel W. Kneller et al. IUCrJ
- A Review of SARS-CoV2: Compared With SARS-CoV and MERS-CoV
- (2021) Huan Zhou et al. Frontiers in Medicine
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
- (2020) Zhenming Jin et al. NATURE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
- (2020) Linlin Zhang et al. SCIENCE
- Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
- (2020) Chunlong Ma et al. CELL RESEARCH
- Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography
- (2020) Daniel W. Kneller et al. Nature Communications
- Sequence Characterization and Molecular Modeling of Clinically Relevant Variants of the SARS-CoV-2 Main Protease
- (2020) Thomas J. Cross et al. BIOCHEMISTRY
- Impact of Early Pandemic Stage Mutations on Molecular Dynamics of SARS-CoV-2 Mpro
- (2020) Olivier Sheik Amamuddy et al. Journal of Chemical Information and Modeling
- SARS-CoV-2 3D database: understanding the coronavirus proteome and evaluating possible drug targets
- (2020) Ali F Alsulami et al. BRIEFINGS IN BIOINFORMATICS
- N‐Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS‐CoV‐2 Main Protease
- (2020) Tomas Koudelka et al. PROTEOMICS
- Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
- (2020) Mohamed Mahdi et al. Virology Journal
- Transmitted Drug Resistance in Newly Diagnosed, Treatment-Naïve, HIV Type 1-Infected Patients in Hungary
- (2019) Éva Áy et al. Journal of Global Antimicrobial Resistance
- Reviewing HIV-1 Gag Mutations in Protease Inhibitors Resistance: Insights for Possible Novel Gag Inhibitor Designs
- (2019) Chinh Tran-To Su et al. MOLECULES
- Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society–USA Panel
- (2018) Huldrych F Günthard et al. CLINICAL INFECTIOUS DISEASES
- Origin and evolution of pathogenic coronaviruses
- (2018) Jie Cui et al. NATURE REVIEWS MICROBIOLOGY
- PDBsum: Structural summaries of PDB entries
- (2017) Roman A. Laskowski et al. PROTEIN SCIENCE
- Highly resistant HIV-1 proteases and strategies for their inhibition
- (2015) Irene T Weber et al. Future Medicinal Chemistry
- HIV-1 assembly, release and maturation
- (2015) Eric O. Freed NATURE REVIEWS MICROBIOLOGY
- Inhibition Profiling of Retroviral Protease Inhibitors Using an HIV-2 Modular System
- (2015) Mohamed Mahdi et al. Viruses-Basel
- HIV infection
- (2015) Steven G. Deeks et al. Nature Reviews Disease Primers
- Coronavirus infection, ER stress, apoptosis and innate immunity
- (2014) To S. Fung et al. Frontiers in Microbiology
- Molecular basis of human immunodeficiency virus type 1 drug resistance: Overview and recent developments
- (2013) Luis Menéndez-Arias ANTIVIRAL RESEARCH
- Substrate Envelope-Designed Potent HIV-1 Protease Inhibitors to Avoid Drug Resistance
- (2013) Madhavi N.L. Nalam et al. CHEMISTRY & BIOLOGY
- Boceprevir
- (2013) Drugs in research & development
- HIV-1 Antiretroviral Drug Therapy
- (2013) E. J. Arts et al. Cold Spring Harbor Perspectives in Medicine
- HIV DNA Integration
- (2013) R. Craigie et al. Cold Spring Harbor Perspectives in Medicine
- The Prevalence of Transmitted Drug Resistance in Newly Diagnosed HIV-Infected Individuals in Croatia: The Role of Transmission Clusters of Men Who Have Sex with Men Carrying the T215S Surveillance Drug Resistance Mutation
- (2012) Ivana Grgic et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Broad-Spectrum Antivirals against 3C or 3C-Like Proteases of Picornaviruses, Noroviruses, and Coronaviruses
- (2012) Y. Kim et al. JOURNAL OF VIROLOGY
- The structural biology of HIV-1: mechanistic and therapeutic insights
- (2012) Alan Engelman et al. NATURE REVIEWS MICROBIOLOGY
- HIV Gag polyprotein: processing and early viral particle assembly
- (2012) Neil M. Bell et al. TRENDS IN MICROBIOLOGY
- The origin of genetic diversity in HIV-1
- (2012) Redmond P. Smyth et al. VIRUS RESEARCH
- Ritonavir-boosted protease inhibitors in HIV therapy
- (2011) Mark W. Hull et al. ANNALS OF MEDICINE
- LigPlot+: Multiple Ligand–Protein Interaction Diagrams for Drug Discovery
- (2011) Roman A. Laskowski et al. Journal of Chemical Information and Modeling
- Accessory Mutations Maintain Stability in Drug-Resistant HIV-1 Protease
- (2011) Max W. Chang et al. JOURNAL OF MOLECULAR BIOLOGY
- Profiling of Substrate Specificities of 3C-Like Proteases from Group 1, 2a, 2b, and 3 Coronaviruses
- (2011) Chi-Pang Chuck et al. PLoS One
- Mutation of Glu-166 Blocks the Substrate-Induced Dimerization of SARS Coronavirus Main Protease
- (2010) Shu-Chun Cheng et al. BIOPHYSICAL JOURNAL
- Profiling of Substrate Specificity of SARS-CoV 3CLpro
- (2010) Chi-Pang Chuck et al. PLoS One
- Comparative Studies on Retroviral Proteases: Substrate Specificity
- (2010) József Tözsér Viruses-Basel
- Molecular Basis for Drug Resistance in HIV-1 Protease
- (2010) Akbar Ali et al. Viruses-Basel
- Fifteen years of HIV Protease Inhibitors: raising the barrier to resistance
- (2009) Annemarie M.J. Wensing et al. ANTIVIRAL RESEARCH
- Transmission of Drug‐Resistant HIV‐1 Is Stabilizing in Europe
- (2009) Jurgen Vercauteren et al. JOURNAL OF INFECTIOUS DISEASES
- Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update
- (2009) Diane E. Bennett et al. PLoS One
- HIV-1 Protease: Structural Perspectives on Drug Resistance
- (2009) Irene Weber et al. Viruses-Basel
- Current and Novel Inhibitors of HIV Protease
- (2009) Jana Pokorná et al. Viruses-Basel
- Tipranavir resistance associated mutations in protease inhibitor-naïve patients with HIV-1 subtype A/E infection
- (2008) Somnuek Sungkanuparph et al. JOURNAL OF CLINICAL VIROLOGY
- Design of HIV Protease Inhibitors Targeting Protein Backbone: An Effective Strategy for Combating Drug Resistance
- (2007) Arun K. Ghosh et al. ACCOUNTS OF CHEMICAL RESEARCH
- HIV-1 protease inhibitors: effects on HIV-2 replication and resistance
- (2007) Luis Menéndez-Arias et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started